Full Text Full Text (PDF) Data Supplement Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Warden, D. Articles by Rush, A. J. Search for Related Content PubMed Citation Articles by Warden, D. Articles by Rush, A. J. Depression

Predictors of Attrition During Initial (Citalopram) Treatment for Depression: A STAR*D Report

OBJECTIVE: Premature attrition from treatment may lead to worse outcomes and compromise the integrity of clinical trials in major depressive disorder. The purpose of this study was to identify the pretreatment predictors of attrition during acute treatment with citalopram in a large, "real world" clinical trial. METHOD: A total of 4,041 adult outpatients with nonpsychotic major depressive disorder were enrolled in treatment with citalopram for up to 14 weeks. Attrition was defined as "immediate" (patients who attended a baseline visit only) or "later" (patients who attended at least one postbaseline visit but who dropped out before the 12-week visit). RESULTS: Overall, 26% of enrolled patients dropped out of the acute phase treatment for nonmedical reasons. Of these, 34% dropped out immediately, 59% dropped out by week 12, and 7% dropped out after 12 weeks. Immediate attrition was associated with younger age, less education, and higher perceived mental health functioning. Attrition later in treatment was associated with younger age, less education, and African American race. Experience with more than one episode of depression was associated with less attrition. CONCLUSIONS: In clinical trials and clinical practice, several time points in treatment may provide opportunities to engage and encourage populations at higher risk for attrition and populations with high-risk presentation of illness. Additionally, more aggressive forms of treatment implemented earlier in the treatment process in order to increase the likelihood of more rapid efficacy may reduce dropout rates.

This article has been cited by other articles:

				D. L. Shern and H. Moran STAR*D: Helping to Close the Gap Between Science and Practice Psychiatr Serv, November 1, 2009; 60(11): 1458 - 1459. [Abstract] [Full Text] [PDF]

				R. Freedman Genetic Investigation of Race and Addiction Am J Psychiatry, September 1, 2009; 166(9): 967 - 968. [Full Text] [PDF]

				H. Gardarsdottir, T. C. Egberts, J. J. Stolker, and E. R. Heerdink Duration of Antidepressant Drug Treatment and Its Influence on Risk of Relapse/Recurrence: Immortal and Neglected Time Bias Am. J. Epidemiol., August 1, 2009; 170(3): 280 - 285. [Abstract] [Full Text] [PDF]

				K. Ell, B. Xie, and P.-J. Lee In Reply J. Clin. Oncol., April 1, 2009; 27(10): 1730 - 1731. [Full Text] [PDF]

				A. Jerant, B. P. Chapman, P. Duberstein, and P. Franks Is Personality a Key Predictor of Missing Study Data? An Analysis From a Randomized Controlled Trial Ann. Fam. Med, March 1, 2009; 7(2): 148 - 156. [Abstract] [Full Text] [PDF]

				I. Lesser, S. Zisook, D. Flores, A. Sciolla, S. Wisniewski, I. Cook, M. Epstein, A. Rosales, C. Gonzalez, M. Trivedi, et al. Depression Outcomes of Spanish- and English-Speaking Hispanic Outpatients in STAR*D Psychiatr Serv, November 1, 2008; 59(11): 1273 - 1284. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2007 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us